HURVITZ CHAIM purchased 500K shares of NRX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $514.9K. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 11/21/2022ACC: 0000950142-22-003233
+662.66K
Net shares
Net buyer
$514.9K
Total acquired
3
Open market trades
3B · 0S
4
Total transactions
662.66K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+287.81K
Price / share
$0.99
Trade value
$284.93K
% of position
New position
11/16/2022
0.00→287.81K
Common Stock
Direct
Shares
+171.78K
Price / share
$1.08
Trade value
$185.52K
% of position
59.7%
11/17/2022
287.81K→459.59K
Common Stock
Direct
Shares
+40.41K
Price / share
$1.10
Trade value
$44.45K
% of position
8.8%
11/18/2022
459.59K→500K
Total
Net shares
+500K
Net value
$514.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/16/2022 | P · Purchase | +287.81K | $0.99 | $284.93K | New position | 0.00 | 287.81K |
| Common Stock Direct | 11/17/2022 | P · Purchase | +171.78K | $1.08 | $185.52K | 59.7% | 287.81K | 459.59K |
| Common Stock Direct | 11/18/2022 | P · Purchase | +40.41K | $1.10 | $44.45K | 8.8% | 459.59K | 500K |
| Total | +500K | $514.91K | ||||||
Derivative Transactions1
Employee Stock Option
Direct
Converts to
Common Stock
162.66K shares
Shares
+162.66K
Strike price
0.75
Held after
381.08K
Exercisable
—
10/21/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option Direct | Common Stock162.66K shares | 10/21/2022 | A · Award | +162.66K | 0.75 | — | 381.08K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.44M
Common Stock
IndirectShares owned208.44K
Total
1.64M indirect1.64M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.44M | Indirect |
| Common Stock | 208.44K | Indirect |
| Total | 1.64M | 1.64M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported